The data presented here demonstrated a possible role for CTSO in resistance to tamoxifen, since the down-regulation of CTSO led to the inhibition of cell growth and increased BRCA1 protein level through both regulation of BRCA1 transcription factors and BRCA1 protein degradation in ER+ breast cancer cells. The gene discussed is BRCA1; the disease is breast cancer.